Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

25 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/25/3194273/0/en/Immuneering-to-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

12 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/12/3186758/0/en/Immuneering-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-and-Clinical-Updates.html

04 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/04/3180862/0/en/Immuneering-to-Report-Third-Quarter-2025-Financial-Results-and-Provide-New-Clinical-Case-Studies-on-Wednesday-November-12-2025.html

26 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/26/3157242/0/en/Immuneering-to-Discuss-Recently-Announced-Overall-Survival-Data-from-Phase-2a-Clinical-Trial-of-Atebimetinib-mGnP-in-First-Line-Pancreatic-Cancer-Patients-on-Monday-September-29-20.html

25 Sep 2025
// BIOSPACE
https://www.biospace.com/drug-development/immuneering-asset-nearly-doubles-overall-survival-in-pancreatic-cancer-after-9-months

25 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/25/3155961/0/en/Immuneering-Announces-Pricing-of-175-Million-Underwritten-Public-Offering-of-Class-A-Common-Stock-and-Concurrent-25-Million-Private-Placement-of-Class-A-Common-Stock-to-Sanofi.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE